RAD51 and colorectal carcinoma: Similarly, Arena et al. [133] showed that increased RAD51 foci formation, a functional biomarker of HR repair, was connected with resistance to the PARPI olaparib in patient-derived CRC models enriching for KRAS and BRAF mutations.